Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-002849

General Counsel sold 1,200 shares at $27.14 ($32,568)

  • General Counsel acquired 1,200 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ring Christine General Counsel 2022-01-10 Option exercise +1,200 $1.86 $2,232 2,486 D: show line 1 in the form
Ring Christine General Counsel 2022-01-10 Sale −1,200 $27.14 $32,568 1,286 D: show line 2 in the form
Open-market sales · 1,200 sh · avg $27.14 · $32,568

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ring Christine General Counsel 2022-01-10 Option exercise · Employee Stock Option (right to buy) −1,200 100,066 D: show line 3 in the form
Loading xslF345X03/doc4.xml…